Abstract:Predictive modeling and understanding of chemical warhead reactivities have the potential to accelerate targeted covalent drug discovery. Recently, the carbanion formation free energies as well as other ground-state electronic properties from density functional theory (DFT) calculations have been proposed as predictors of glutathione reactivities of Michael acceptors; however, no clear consensus exists. By profiling the thiol-Michael reactions of a diverse set of singly- and doubly-activated olefins, including several model warheads related to afatinib, here we reexamined the question of whether low-cost electronic properties can be used as predictors of reaction barriers. The electronic properties related to the carbanion intermediate were found to be strong predictors, e.g., the change in the Cβ charge accompanying carbanion formation. The least expensive reactant-only properties, the electrophilicity index, and the Cβ charge also show strong rank correlations, suggesting their utility as quantum descriptors. A second objective of the work is to clarify the effect of the β-dimethylaminomethyl (DMAM) substitution, which is incorporated in the warheads of several FDA-approved covalent drugs. Our data suggest that the β-DMAM substitution is cationic at neutral pH in solution and promotes acrylamide's intrinsic reactivity by enhancing the charge accumulation at Cα upon carbanion formation. In contrast, the inductive effect of the β-trimethylaminomethyl substitution is diminished due to steric hindrance. Together, these results reconcile the current views of the intrinsic reactivities of acrylamides and contribute to large-scale predictive modeling and an understanding of the structure-activity relationships of Michael acceptors for rational TCI design.

Development and Application of Novel Electrophilic Warheads in Target Identification and Drug Discovery

Advanced Approaches of Developing Targeted Covalent Drugs

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update

Novel Electrophilic Warhead Targeting a Triple-Negative Breast Cancer Driver in Live Cells Revealed by "inverse Drug Discovery".

Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Molecular Bidents with Two Electrophilic Warheads as a New Pharmacological Modality

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Recent advances in the design of small molecular drugs with acrylamides covalent warheads

Activity-Based Hydrazine Probes for Protein Profiling of Electrophilic Functionality in Therapeutic Targets

Recent advances and method development for drug target identification

A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins

A Perspective on Covalent Inhibitors: Research and Development Trends of Warheads and Targets

Catalyst-Free Late-Stage Functionalization to Assemble α-acyloxyenamide Electrophiles for Selectively Profiling Conserved Lysine Residues

Chemoproteomics-enabled Development of Novel Cysteine and Serine Reactive Small Molecules: from Target Identification to Inhibitor Discovery

Advances In The Development Of Aptamer Drug Conjugates For Targeted Drug Delivery

Quantum Descriptors for Predicting and Understanding the Structure–Activity Relationships of Michael Acceptor Warheads

Advances in the Development of Aptamer Drug Conjugates for Targeted Drug Delivery.

Cu(II)-Assisted Novel Covalent Warheads for Proteome-wide Cysteine Profiling

ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries